This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 2001 Aug;114(2):489-91.

doi: 10.1046/j.1365-2141.2001.02937-4.x.

Interpretation of inflammatory markers in feverish cancer patients with or without neutropenia at admission

E S De Bont, C Oude Nijhuis, W A Kamps, E Vellenga

PMID: 11529876
DOI: 10.1046/j.1365-2141.2001.02937-4.x

Comparative Study

Interpretation of inflammatory markers in feverish cancer patients with or without neutropenia at admission

E S De Bont et al. Br J Haematol. 2001 Aug.

. 2001 Aug;114(2):489-91.

doi: 10.1046/j.1365-2141.2001.02937-4.x.

Authors

E S De Bont, C Oude Nijhuis, W A Kamps, E Vellenga

PMID: 11529876
DOI: 10.1046/j.1365-2141.2001.02937-4.x

No abstract available

PubMed Disclaimer

Comment on

Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia.
de Bont ES, Vellenga E, Swaanenburg JC, Fidler V, Visser-van Brummen PJ, Kamps WA. de Bont ES, et al. Br J Haematol. 1999 Nov;107(2):375-80. doi: 10.1046/j.1365-2141.1999.01707.x. Br J Haematol. 1999. PMID: 10583227
Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II.
Fleischhack G, Kambeck I, Cipic D, Hasan C, Bode U. Fleischhack G, et al. Br J Haematol. 2000 Dec;111(4):1093-102. doi: 10.1046/j.1365-2141.2000.02458.x. Br J Haematol. 2000. PMID: 11167745

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley